• Aucun résultat trouvé

About the diagnosis of acute transfusion-related reaction during cardiopulmonary bypass

N/A
N/A
Protected

Academic year: 2021

Partager "About the diagnosis of acute transfusion-related reaction during cardiopulmonary bypass"

Copied!
15
0
0

Texte intégral

(1)

M Erpicum, F Blaffart, JO Defraigne, C Gérard, R Larbuisson University Hospital of Liège, Belgium

(2)

Acute transfusion-related reactions

Serious adverse or unexpected reactions occurring in a patient within minutes or hours after transfusion

(3)

Acute transfusion-related reactions

Immune Non Immune

Febrile reaction

Allergic/Anaphylactic reaction Lung injury (TRALI)

Hemolysis Hemolysis Bacterial infection Hypothermia Metabolic reaction Citrate toxicity

Circulatory overload (TACO)

(4)

Detection

Corrective measures

Hemovigilance procedure

Reporting

Symptoms - Clinical signs

Preventive measures

Transfusion-related reactions

National hemovigilance system

(5)

Rate of transfusion-related reactions

Underestimation

?

?

National

Product quality variability Definitions variability

International

Transfusion practices variability Denominators variability

(6)

Rate of transfusion-related reactions

Red blood cells

Fresh frozen plasma

Platelets

17/100.000 6/100.000

33/100.000

(7)

Detection of acute transfusion-related reactions Chills Rigors Urticaria Chest/Abdominal pain Nausea/Vomiting Malaise/Blackout Dyspnea Flush Rash Jaundice

Symptoms - Clinical signs

Tachycardia Arythmia Hyper/Hypotension Shock Fever Hemoglobinuria Hemoglobinemia Oliguria, anuria Uncontrolled bleeding

(8)

Fever-Chills-Rigidity

VO2 ,

pCO2,

lactates Erythema-Flushing-Urticaria

BP

Pulmonary oedema Difficult weaning from CPB

Vasomotor instability

CIVD/ DIC Uncontrolled bleeding

Hburia , ↓ Hb,

MetHb,

K+

Hemolysis

(9)
(10)

1. Avoid transfusion

2. Delay transfusion => after wean off CPB 3. In case of transfusion

Check identity of patient vs patient identity on blood product label

Urine output – Urine color Hb - Met Hb values

Blood pressure K+

VO2

pCO2, lactates

Before, during and after transfusion

(11)

Uncontrolled bleeding ?

Difficult to wean off CPB ?

Any suspicious change ?

Transfusion effectiveness ?

(12)

Maybe nothing…

Maybe another thing…

(13)

4. In any suspicion of a transfusion-related reaction:

1. Avoid transfusion

2. Delay transfusion => after wean off CPB 3. In case of transfusion

Check identity of patient vs patient identity on blood product label

Stop transfusion

Notify physician and blood bank

Residual blood product(s) to blood bank Collect blood sample

(14)

The risk of a severe transfusion reaction is low

Detection is difficult in the setting of CPB

BUT

Detection and report are essential measures

in a hemovigilance goal

(15)

Better informed patients, nurses,

physicians and laboratory personnel

Références

Documents relatifs

 Les sérums dont le dépistage est positif en anticorps anti-HLA de classe I et négatif en anticorps anti-HLA de classe II par technique Luminex™ et dont seule la

Magnetic susceptibility from EPR and from SQUID show a standard Curie-Weiss behavior and no sign of effect of the ferroelectric transition is observed, leading to the conclusion

Figure 34 - Classfication des vecteurs afin de les relier à une classe distincte. 1) Permet de spécifier le nombre de centroïdes (K) du classifieur K-Means. 2) Permet de

Dans le cas d’une transfusion de globules rouges, afin d’identifier le produit sanguin vous correspondant le mieux, l’échantillon de votre sang sera également analysé

Il a constate que dans certain plasma ; il y a des anticorps ou agglutinines qui sont deux type agglutinine «anti-A»; agglutinine «anti-B» et d autre sans agglutinine.. De cela

Obligatoire depuis 1965 et redéfinit par la Circulaire du 15 décembre 2003, le Contrôle Ultime Pré-Transfusionnel permet de sécuriser l’acte transfusionnel par la

• Identification immédiatement après le prélèvement, au chevet du patient avec une étiquette qui comporte l’identité complète du patient : nom de naissance, prénom,

Diminuer la quantité de plaquettes à transfuser sans modifier la concentration du produit Assurer une deuxième transfusion à partir du même don. Cryoconservation CPA de phénotype